Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

KP 103

Known as: KP-103, KP103 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
  • 2018
  • Corpus ID: 13702793
BIOLOGICAL ACTIVITY: Bifonazole is an imidazole antifungal drug. Target: Antifungal Bifonazole, a new broad-spectrum antimycotic… Expand
Is this relevant?
Review
2014
Review
2014
Background: Topical therapies for onychomycosis are associated with less adverse events than systemic therapies, but poor nail… Expand
  • table 1
  • table 2
Is this relevant?
2002
2002
ABSTRACT The therapeutic efficacy of KP-103, a novel topical triazole, in a guinea pig tinea unguium model was investigated… Expand
Is this relevant?
2002
2002
The therapeutic efficacy of KP-103, a triazole derivative, for 10 guinea pigs with interdigital tinea pedis or tinea corporis was… Expand
Is this relevant?
2002
2002
We developed a new technique for culture study that successfully recovers fungi from drug-treated skin tissues, in which tissue… Expand
Is this relevant?
2001
2001
ABSTRACT The in vitro activity of KP-103, a novel triazole derivative, against pathogenic fungi that cause dermatomycoses and its… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?